Autoimmune disease patients worry about drug shortage amid COVID-19 crisis
4 years ago
28
Last month, the U.S. Food and Drug Administration issued an Emergency Use Authorization for hydroxychloroquine sulfate and chloroquine phosphate to be used to treat certain hospitalized patients with COVID-19.
Loading comments...
-
2:04
WFTS
7 months agoOngoing storm repairs in St. Petersburg neighborhood
172 -
2:14
KSHB
4 years agoCOVID-19 leads to hydroxychloroquine shortage for patients with autoimmune disease
151 -
1:18
WFTX
4 years agoHomeless worry about shelters closing amid the Coronavirus crisis
50 -
2:10
WKBW
4 years agoDay care workers worry about COVID-19 exposure
63 -
1:57
KGTV
4 years agoLupus patients unable to get drug due to COVID-19
257 -
1:48
KSHB
4 years agoAlzheimer's, dementia patients face additional challenges amid COVID-19
14 -
1:34
Newsy
4 years agoTherapeutic Drug Could Help Keep COVID-19 Patients Off Ventilators
816 -
1:44
Newsy
4 years agoTherapeutic Drug Could Help Keep COVID-19 Patients Off Ventilators
234 -
2:11
KNXV
4 years agoNurse on a designated COVID-19 floor speaking out about working with coronavirus patients
372 -
1:51
KGTV
4 years agoDesigned for something else, SD company tests drug on COVID-19 patients
14
